Issue 26 David Chang, M.D., Chief, Section of Reconstructive Surgery Prof., Uni. of Chicago Medicine
February 2023 As a world-renowned plastic and reconstructive surgeon, can you reflect on your reasons and motivations that pushed you to...
Issue 26 David Chang, M.D., Chief, Section of Reconstructive Surgery Prof., Uni. of Chicago Medicine
Artificial Intelligence in Drug Discovery and Biotech; 2022 Recap and Key Trends
Syntekabio's STB CLOUD is Transforming the Biopharma Industry
17 Companies Building the Future of Drug Development on a Chip
K-Blockbuster Project Companies
Issue 25 Eul-Sik Yoon, M.D., Ph.D., Chairman, Korean Society of Plastic and Reconstructive Surgeons
Latest Update for Surgical Treatment of Lymphedema
Innovative Value-Based Price Programs Back in the Spotlight
Conference Alerts_Issue25
Upper Middle-Income Countries Left Out by New Merck/Ridgeback COVID-19 Antiviral Licensing Deal